Skip to content
Other

Adjustment For Amortization

West Pharmaceutical Services Adjustment For Amortization decreased by 14.3% to $600K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $900K to $600K.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_adjustment_for_amortization

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$1.1M$1.1M$900K$900K$900K$900K$500K$900K$900K$900K$900K$900K$600K$700K$600K
QoQ Change+0.0%-18.2%+0.0%+0.0%+0.0%-44.4%+80.0%+0.0%+0.0%+0.0%+0.0%-33.3%+16.7%-14.3%
YoY Change-18.2%-18.2%+0.0%-44.4%+0.0%+0.0%+80.0%+0.0%+0.0%-33.3%-22.2%-33.3%
Range$500K$1.1M
CAGR-15.9%
Avg YoY Growth-7.5%
Median YoY Growth-9.1%

Frequently Asked Questions

What is West Pharmaceutical Services's adjustment for amortization?
West Pharmaceutical Services (WST) reported adjustment for amortization of $600K in Q1 2026.
How has West Pharmaceutical Services's adjustment for amortization changed year-over-year?
West Pharmaceutical Services's adjustment for amortization decreased by 33.3% year-over-year, from $900K to $600K.